Naveris
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
21 Hickory Dr Ste 600, Waltham, Massachu...Phone Number
(833) 628-3747Website
www.naveris.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
2
1
1
1
About Naveris
Naveris specializes in developing highly sensitive blood tests for the early detection of viral cancers, significantly improving upon traditional methods like scans and biopsies. Their flagship product, NavDx, is a liquid biopsy that utilizes proprietary technology for ultrasensitive surveillance of HPV-related cancers. The company aims to transform cancer detection and enhance patient outcomes through non-invasive testing and real-time monitoring of treatment responses. Naveris serves both patients and physicians, focusing on optimizing cancer surveillance and detecting recurrences in patients in remission.Explore more
Naveris Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Naveris your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Naveris
Click to see if Naveris had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Naveris recently announced quarterly report
Naveris, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Naveris has new funding data
Check if Naveris has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Naveris launches new products
Check out if Naveris is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Naveris
Compare insights from companies similar to Naveris, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Naveris is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Naveris is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Naveris.
Naveris financials insights
Gather financial insights about Naveris, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$19M
2022
Series A
$51M
Naveris Tech Stack
A closer look at the technologies used by Naveris
See more technologies
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Open Position
Hiring Plans
Naveris has more open roles in Marketing than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Naveris has more open roles in Sales than it has had at any time in the past 6 months.
Hiring Plans
Open Position
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Naveris
Sign Up For FreeTo access detailed company insights
Naveris specializes in developing highly sensitive blood tests for the early detection of viral cancers, significantly improving upon traditional methods like scans and biopsies. Their flagship product, NavDx, is a liquid biopsy that utilizes proprietary technology for ultrasensitive surveillance of HPV-related cancers. The company aims to transfor... Read More
